Compounded topical composition and method

Abstract

A compounded topical composition may include an antiviral component, a topical base component, and a local anesthetic component. The antiviral component may include fine powder obtained by grinding oral tablets of one or more antiviral actives. The topical component may include the local anesthetic component. The local anesthetic component may be present in an amount between about 2% and about 8% by weight of the compounded topical composition and the antiviral component may be present in an amount between 4% and 12% by weight of the compounded topical composition. The antiviral component may include acyclovir, valaciclovir, penciclovir, famciclovir, or combinations thereof, and the topical base component may be a lidocaine topical, a lidocaine and prilocaine topical, or both.

What is claimed is: 
     
         1 . A compounded topical composition comprising:
 an antiviral component comprising one or more ground oral tablets of at least one antiviral selected from acyclovir, valaciclovir, penciclovir, famciclovir, or a combination thereof, wherein the one or more ground oral tablets are dissolved, suspended, or combination thereof in the compounded topical composition;   a topical local anesthetic component comprising (a) a lidocaine 5% ointment containing the local anesthetic lidocaine in an amount 5% by weight, (b) a lidocaine 2.5% and prilocaine 2.5% cream containing the local anesthetics lidocaine and prilocaine, each in an amount of 2.5% by weight, (c) or both; and   wherein the one or more ground oral tablets of the antiviral component are present in an amount such that the compounded topical composition comprises the antiviral in an amount between about 4% and about 12% by weight of the compounded topical composition.   
     
     
         2 . The compounded topical composition of  claim 1 , wherein the antiviral component comprises one or more ground oral acyclovir tablets containing the antiviral acyclovir present in an amount such that the compounded topical composition comprises the antiviral acyclovir in an amount between about 4% and about 12% by weight. 
     
     
         3 . The compounded topical composition of  claim 2 , wherein the one or more ground oral acyclovir tablets are present in an amount such that the compounded topical composition comprises the antiviral acyclovir in an amount between about 6% and about 9% by weight. 
     
     
         4 . The compounded topical composition of  claim 2 , wherein the one or more ground oral acyclovir tablets are present in an amount such that the compounded topical composition comprises the antiviral acyclovir in an amount about 8% by weight. 
     
     
         5 . The compounded topical composition of  claim 3 , wherein the topical local anesthetic composition comprises the lidocaine 5% ointment, and wherein the lidocaine 5% ointment is present in an amount such that the compounded topical composition comprises the local anesthetic lidocaine in an amount greater than 4% by weight. 
     
     
         6 . The compounded topical composition of  claim 5 , wherein the one or more ground oral acyclovir tablets are present in an amount such that the compounded topical composition comprises the antiviral acyclovir in an amount about 8% by weight and lidocaine in an amount about 4.5% by weight. 
     
     
         7 . The compounded topical composition of  claim 3 , wherein the topical local anesthetic composition comprises the lidocaine 2.5% and prilocaine 2.5% cream, and wherein the lidocaine 2.5% and prilocaine 2.5% cream is present in an amount such that the compounded topical composition comprises each of the local anesthetics lidocaine and prilocaine in an amount between about 1.5% and about 2.25% by weight. 
     
     
         8 . The compounded topical composition of  claim 7 , wherein the one or more ground oral acyclovir tablets and the lidocaine 2.5% and prilocaine 2.5% cream are present in amounts such that the compounded topical composition comprises the antiviral acyclovir in an amount about 8% by weight and each of the local anesthetics lidocaine and prilocaine in an amount about 2.25% by weight. 
     
     
         9 . The compounded topical composition of  claim 1 , wherein the antiviral component comprises one or more ground oral acyclovir tablets containing the antiviral acyclovir and at least one of (a) one or more ground oral valaciclovir tablets containing the antiviral valaciclovir or (b) one or more ground oral famciclovir tablets containing the antiviral famciclovir. 
     
     
         10 . The compounded topical composition of  claim 9 , wherein the topical local anesthetic composition comprises the lidocaine 5% ointment, and wherein the lidocaine 5% ointment and the one or more ground oral acyclovir tablets and the at least one of (a) the one or more ground oral valaciclovir tablets or (b) the one or more ground oral famciclovir tablets are present in amounts such that the compounded topical composition comprises the antivirals acyclovir and the at least one of valaciclovir or famciclovir in a combined amount between about 6% and about 9% by weight and the local anesthetic lidocaine in an amount greater than 4% by weight. 
     
     
         11 . The compounded topical composition of  claim 10 , wherein the lidocaine 5% ointment and the one or more ground oral acyclovir tablets and the at least one of (a) the one or more ground oral valaciclovir tablets or (b) the one or more ground oral famciclovir tablets are present in amounts such that the compounded topical composition comprises the antivirals acyclovir and the at least one of valaciclovir or famciclovir in a combined amount about 8% by weight and the local anesthetic lidocaine in an amount about 4.5% by weight. 
     
     
         12 . The compounded topical composition of  claim 9 , wherein the topical local anesthetic composition comprises the lidocaine 2.5% and lidocaine 2.5% cream, and wherein the lidocaine 2.5% and prilocaine 2.5% cream and the one or more ground oral acyclovir tablets and the at least one of (a) the one or more ground oral valaciclovir tablets or (b) the one or more ground oral famciclovir tablets are present in amounts such that the compounded topical composition comprises the antivirals acyclovir and at least one of valaciclovir or famciclovir in a combined amount between about 6% and about 9% by weight and each of the local anesthetics lidocaine and prilocaine in an amount between about 1.5% and about 2.25% by weight. 
     
     
         13 . The compounded topical composition of  claim 12 , wherein the lidocaine 2.5% and prilocaine 2.5% cream and the one or more ground oral acyclovir tablets and the at least one of (a) the one or more ground oral valaciclovir tablets or (b) the one or more ground oral famciclovir tablets are present in amounts such that the compounded topical composition comprises the antivirals acyclovir and at least one of valaciclovir or famciclovir in a combined amount about 8% by weight and each of the local anesthetics lidocaine and prilocaine in an amount about 2.25% by weight. 
     
     
         14 . The compounded topical composition of  claim 1 , wherein the antiviral component comprises at least one of (a) one or more ground oral valaciclovir tablets containing the antiviral valaciclovir or (b) one or more ground oral famciclovir tablets containing the antiviral famciclovir, and wherein the topical local anesthetic composition comprises the lidocaine 5% ointment. 
     
     
         15 . The compounded topical composition of  claim 14 , wherein the lidocaine 5% ointment and the at least one of (a) the one ground oral valaciclovir tablets or (b) the one or more ground oral famciclovir tablets are present in amounts such that the topical compounded composition comprises the at least one antiviral valaciclovir or famciclovir in a combined amount between about 6% and about 9% by weight and the local anesthetic lidocaine in an amount greater than 4% by weight. 
     
     
         16 . The compounded topical composition of  claim 15 , wherein the lidocaine 5% ointment and the at least one of (a) the one ground oral valaciclovir tablets or (b) the one or more ground oral famciclovir tablets are present in amounts such that the topical compounded composition comprises the at least one antiviral valaciclovir or famciclovir in a combined amount about 8% by weight and the local anesthetic lidocaine in an amount about 4.5% by weight. 
     
     
         17 . The compounded topical composition of  claim 1 , wherein the antiviral component comprises at least one of (a) one or more ground oral valaciclovir tablets containing the antiviral valaciclovir or (b) one or more ground oral famciclovir tablets containing the antiviral famciclovir, and wherein the topical local anesthetic composition comprises the 2.5% and prilocaine 2.5% cream. 
     
     
         18 . The compounded topical composition of  claim 17 , wherein the lidocaine 2.5% and prilocaine 2.5% cream and the at least one of (a) the one ground oral valaciclovir tablets or (b) the one or more ground oral famciclovir tablets are present in amounts such that the topical compounded composition comprises the at least one antiviral valaciclovir or famciclovir in a combined amount between about 6% and about 9% by weight and each of the local anesthetics lidocaine and prilocaine in an amount between about 1.5% and about 2.25% by weight. 
     
     
         19 . The compounded topical composition of  claim 18 , wherein the lidocaine 2.5% and prilocaine 2.5% cream and the at least one of (a) the one ground oral valaciclovir tablets or (b) the one or more ground oral famciclovir tablets are present in amounts such that the topical compounded composition comprises the at least one antiviral valaciclovir or famciclovir in a combined amount about 8% by weight and each of the local anesthetics lidocaine and prilocaine in an amount about 2.25% by weight.